SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Meyler's Side Effects of Drugs, 2016,

    CrossRef

  2. 2
    Amanda L. McDonell, Ulrich Wahn, Dirk Demuth, Catrina Richards, Charlie Hawes, Jakob Nørgaard Andreasen, Felicia Allen-Ramey, Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis, Allergy, Asthma & Clinical Immunology, 2015, 11, 1

    CrossRef

  3. 3
    George V Guibas, Spyridon Megremis, Peter West, Nikolaos G Papadopoulos, Contributing factors to the development of childhood asthma: working toward risk minimization, Expert Review of Clinical Immunology, 2015, 11, 6, 721

    CrossRef

  4. 4
    Thomas M. Kündig, Ludger Klimek, Philipp Schendzielorz, Wolfgang A. Renner, Gabriela Senti, Martin F. Bachmann, Is The Allergen Really Needed in Allergy Immunotherapy?, Current Treatment Options in Allergy, 2015, 2, 1, 72

    CrossRef

  5. You have free access to this content5
    N. G. Papadopoulos, J. A. Bernstein, P. Demoly, M. Dykewicz, W. Fokkens, P. W. Hellings, A. T. Peters, C. Rondon, A. Togias, L. S. Cox, Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report, Allergy, 2015, 70, 5
  6. 6
    Samantha R. Gendelman, David M. Lang, Sublingual Immunotherapy in the Treatment of Atopic Dermatitis: a Systematic Review Using the GRADE System, Current Allergy and Asthma Reports, 2015, 15, 2

    CrossRef

  7. 7
    Cemal Cingi, Nuray Bayar Muluk, Deniz Hanci, Seckin Ulusoy, Fezan Sahin, Updating the role played by immunotherapy for allergic rhinitis: meta-analysis, International Forum of Allergy & Rhinology, 2015, 5, 2
  8. 8
    Carmen Vidal, Pablo Rodríguez del Río, Ana Tabar, Carmen Moreno, Allergen Immunotherapy (AIT) in Allergic Rhinitis: Long-Term Efficacy and the Development of Asthma. What Do We Know?, Current Treatment Options in Allergy, 2014, 1, 1, 14

    CrossRef

  9. 9
    G. Dutau, Allergie aux acariens domestiques : du diagnostic à la prise en charge, Revue Française d'Allergologie, 2014, 54, 8, 544

    CrossRef

  10. 10
    Cheryl S. Hankin, Linda Cox, Allergy immunotherapy, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 4, 363

    CrossRef

  11. 11
    Linda S. Cox, Cheryl Hankin, Richard Lockey, Allergy Immunotherapy Adherence and Delivery Route: Location Does Not Matter, The Journal of Allergy and Clinical Immunology: In Practice, 2014, 2, 2, 156

    CrossRef

  12. 12
    Oliver Pfaar, Claus Bachert, Albrecht Bufe, Roland Buhl, Christof Ebner, Peter Eng, Frank Friedrichs, Thomas Fuchs, Eckard Hamelmann, Doris Hartwig-Bade, Thomas Hering, Isidor Huttegger, Kirsten Jung, Ludger Klimek, Matthias Volkmar Kopp, Hans Merk, Uta Rabe, Joachim Saloga, Peter Schmid-Grendelmeier, Antje Schuster, Nicolaus Schwerk, Helmut Sitter, Ulrich Umpfenbach, Bettina Wedi, Stefan Wöhrl, Margitta Worm, Jörg Kleine-Tebbe, Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases, Allergo Journal International, 2014, 23, 8, 282

    CrossRef

  13. 13
    Yoshitaka Okamoto, Nobuo Ohta, Mitsuhiro Okano, Atsushi Kamijo, Minoru Gotoh, Motohiko Suzuki, Sachio Takeno, Tetsuya Terada, Toyoyuki Hanazawa, Shigetoshi Horiguchi, Kohei Honda, Shoji Matsune, Takechiyo Yamada, Atsushi Yuta, Takeo Nakayama, Shigeharu Fujieda, Guiding principles of subcutaneous immunotherapy for allergic rhinitis in Japan, Auris Nasus Larynx, 2014, 41, 1, 1

    CrossRef

  14. 14
    Ludger Klimek, Martin F Bachmann, Gabriela Senti, Thomas M Kündig, Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs, Expert Review of Clinical Immunology, 2014, 10, 8, 1059

    CrossRef

  15. 15
    Oliver Pfaar, Claus Bachert, Albrecht Bufe, Roland Buhl, Christof Ebner, Peter Eng, Frank Friedrichs, Thomas Fuchs, Eckard Hamelmann, Doris Hartwig-Bade, Thomas Hering, Isidor Huttegger, Isidor Huttegger, Kirsten Jung, Ludger Klimek, Matthias Volkmar Kopp, Hans Merk, Uta Rabe, Joachim Saloga, Peter Schmid-Grendelmeier, Antje Schuster, Nicolaus Schwerk, Helmut Sitter, Ulrich Umpfenbach, Bettina Wedi, Stefan Wöhrl, Margitta Worm, Jörg Kleine-Tebbe, Susanne Kaul, Anja Schwalfenberg, Leitlinie zur (allergen-)spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen, Allergo Journal, 2014, 23, 8, 28

    CrossRef

  16. 16
    Zsolt Szépfalusi, Christina Bannert, Leila Ronceray, Elisabeth Mayer, Michaela Hassler, Eva Wissmann, Eleonora Dehlink, Saskia Gruber, Alexandra Graf, Christian Lupinek, Rudolf Valenta, Thomas Eiwegger, Radvan Urbanek, Preventive sublingual immunotherapy in preschool children: First evidence for safety and pro-tolerogenic effects, Pediatric Allergy and Immunology, 2014, 25, 8
  17. 17
    S. Baris, A. Kiykim, A. Ozen, A. Tulunay, E. Karakoc-Aydiner, I. B. Barlan, Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite, Allergy, 2014, 69, 2
  18. 18
    Makoto Yasuda, Takemitsu Hama, Yoko Haenuki, Kotaro Okamoto, Shigeyuki Mukudai, Yasuo Hisa, Effectiveness of Subcutaneous Immunotherapy for Japanese Cedar Pollinosis, Practica oto-rhino-laryngologica. Suppl., 2013, 137, 0, 40

    CrossRef

  19. 19
    Makoto Yasuda, Takemitsu Hama, Yoko Haenuki, Kotaro Okamoto, Shigeyuki Mukudai, Yasuo Hisa, Effectiveness of Subcutaneous Immunotherapy for Japanese Cedar Pollinosis, Practica Oto-Rhino-Laryngologica, 2013, 106, 1, 81

    CrossRef

  20. 20
    A. Didier, H.-J. Malling, M. Worm, F. Horak, G. Sussman, M. Melac, S. Soulié, R. K. Zeldin, Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis, Clinical & Experimental Allergy, 2013, 43, 5
  21. 21
    Samantha R. Gendelman, David M. Lang, Specific immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system, Annals of Allergy, Asthma & Immunology, 2013, 111, 6, 555

    CrossRef

  22. 22
    P. Schendzielorz, L. Klimek, Spezifische Immuntherapie, HNO, 2013, 61, 10, 834

    CrossRef

  23. 23
    M.V. Kopp, M. Bendiks, Spezifische Immuntherapie im Kindesalter, Monatsschrift Kinderheilkunde, 2013, 161, 7, 616

    CrossRef

  24. 24
    Lars Jacobsen, Ulrich Wahn, M Beatrice Bilo, Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy, Clinical and Translational Allergy, 2012, 2, 1, 8

    CrossRef

  25. You have free access to this content25
    N. G. Papadopoulos, H. Arakawa, K.-H. Carlsen, A. Custovic, J. Gern, R. Lemanske, P. Souef, M. Mäkelä, G. Roberts, G. Wong, H. Zar, C. A. Akdis, L. B. Bacharier, E. Baraldi, H. P. Bever, J. Blic, A. Boner, W. Burks, T. B. Casale, J. A. Castro-Rodriguez, Y. Z. Chen, Y. M. El-Gamal, M. L. Everard, T. Frischer, M. Geller, J. Gereda, D. Y. Goh, T. W. Guilbert, G. Hedlin, P. W. Heymann, S. J. Hong, E. M. Hossny, J. L. Huang, D. J. Jackson, J. C. Jongste, O. Kalayci, N. Aït-Khaled, S. Kling, P. Kuna, S. Lau, D. K. Ledford, S. I. Lee, A. H. Liu, R. F. Lockey, K. Lødrup-Carlsen, J. Lötvall, A. Morikawa, A. Nieto, H. Paramesh, R. Pawankar, P. Pohunek, J. Pongracic, D. Price, C. Robertson, N. Rosario, L. J. Rossenwasser, P. D. Sly, R. Stein, S. Stick, S. Szefler, L. M. Taussig, E. Valovirta, P. Vichyanond, D. Wallace, E. Weinberg, G. Wennergren, J. Wildhaber, R. S. Zeiger, International consensus on (ICON) pediatric asthma, Allergy, 2012, 67, 8
  26. You have free access to this content26
    M. A. Calderon, R. Gerth van Wijk, I. Eichler, P. M. Matricardi, E. M. Varga, M. V. Kopp, P. Eng, B. Niggemann, A. Nieto, E. Valovirta, P. A. Eigenmann, G. Pajno, A. Bufe, S. Halken, K. Beyer, U. Wahn, Perspectives on allergen-specific immunotherapy in childhood: An EAACI position statement, Pediatric Allergy and Immunology, 2012, 23, 4
  27. 27
    Linda Cox, Moisés Calderón, Oliver Pfaar, Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost–effectiveness of current and novel formulations, Immunotherapy, 2012, 4, 6, 601

    CrossRef

  28. 28
    Michelle B. Lierl, Allergen Immunotherapy: Shots for Asthma, Wheezing, and Bee Sting, Pediatric Annals, 2011, 40, 4, 192

    CrossRef

  29. 29
    L. Klimek, J. Willers, A. Hammann-Haenni, O. Pfaar, H. Stocker, P. Mueller, W. A. Renner, M. F. Bachmann, Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study, Clinical & Experimental Allergy, 2011, 41, 9
  30. 30
    Zsolt Szépfalusi, Saskia Gruber, Thomas Eiwegger, Eleonora Dehlink, Clinical practice, European Journal of Pediatrics, 2011, 170, 2, 137

    CrossRef

  31. 31
    Yekaterina A. Koshkareva, John H. Krouse, Immunotherapy – Traditional, Otolaryngologic Clinics of North America, 2011, 44, 3, 741

    CrossRef

  32. 32
    E. Gadermaier, J. Staikuniene, S. Scheiblhofer, J. Thalhamer, M. Kundi, K. Westritschnig, I. Swoboda, S. Flicker, R. Valenta, Recombinant allergen–based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation, Allergy, 2011, 66, 9
  33. 33
    Linda Cox, Dana Wallace, Specific Allergy Immunotherapy for Allergic Rhinitis: Subcutaneous and Sublingual, Immunology and Allergy Clinics of North America, 2011, 31, 3, 561

    CrossRef

  34. 34
    Giovanni Passalacqua, Specific immunotherapy: beyond the clinical scores, Annals of Allergy, Asthma & Immunology, 2011, 107, 5, 401

    CrossRef

  35. 35
    Paolo Maria Matricardi, Piotr Kuna, Valentina Panetta, Ulrich Wahn, Annemie Narkus, Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on meta-analyses, Journal of Allergy and Clinical Immunology, 2011, 128, 4, 791

    CrossRef

  36. 36
    Cheryl S. Hankin, Linda Cox, David Lang, Amy Bronstone, Paul Fass, Bryan Leatherman, Zhaohui Wang, Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study, Annals of Allergy, Asthma & Immunology, 2010, 104, 1, 79

    CrossRef

  37. 37
    Zsolt Szépfalusi, Saskia Gruber, Eiwegger Thomas, Eleonora Dehlink, Allergen-spezifische Immuntherapie bei Kindern und Jugendlichen, Pädiatrie & Pädologie, 2010, 45, 6, 10

    CrossRef

  38. 38
    Christos Georgalas, Ingrid Terreehorst, Wytske Fokkens, Current management of allergic rhinitis in children, Pediatric Allergy and Immunology, 2010, 21, 1-Part-II
  39. 39
    F. Rancé, A. Deschildre, E. Bidat, J. Just, L. Couderc, S. Wanin, L. Weiss, Prévention secondaire et tertiaire de l’asthme allergique de l’enfant, Revue des Maladies Respiratoires, 2010, 27, 10, 1221

    CrossRef

  40. 40
    C. Barth, F. Anero, O. Pfaar, L. Klimek, K. Hörmann, B. A. Stuck, Safety aspects of subcutaneous immunotherapy with multiple allergens—a retrospective analysis on polysensitized patients, European Archives of Oto-Rhino-Laryngology, 2010, 267, 12, 1873

    CrossRef

  41. 41
    Erika von Mutius, Matthias Griese, Ludger Klimek, Pädiatrische HNO-Heilkunde, 2010,

    CrossRef

  42. 42
    &NA;, CHAPTER 6: IMPACT OF SUBLINGUAL IMMUNOTHERAPY ON THE NATURAL HISTORY OF RESPIRATORY ALLERGY, World Allergy Organization Journal, 2009, 2, 11, 261

    CrossRef

  43. 43
    F. Rancé, A. Deschildre, É. Bidat, J. Just, L. Couderc, S. Wanin, L. Weiss, Prévention secondaire et tertiaire de l’asthme allergique de l’enfant, Revue Française d'Allergologie, 2009, 49, 8, 585

    CrossRef

  44. 44
    Barbara Rogala, Joanna Glück, Risks and benefits of allergen immunotherapy, Expert Opinion on Drug Safety, 2009, 8, 3, 253

    CrossRef

  45. 45
    Zsolt Szépfalusi, Waltraud Emminger, Franz Eitelberger, Manfred Götz, Andrea Grillenberger, Elisabeth Horak, Isidor Huttegger, Dieter Koller, Helmut Litscher, Rudolf Schmitzberger, Eva-Maria Varga, Josef Riedler, Spezifische Immuntherapie bei IgE-vermittelten allergischen Erkrankungen im Kindes- und Jugendalter – eine Übersicht über in Österreich zugelassene/registrierte Allergenpräparate, Wiener klinische Wochenschrift, 2009, 121, 19-20, 648

    CrossRef

  46. 46
    Hyo-Bin Kim, Hyun-Seung Jin, So-Yeon Lee, Ja-Hyeong Kim, Bong-Seong Kim, Seong Jong Park, Soo-Jong Hong, The Effect of Rush Immunotherapy with House Dust Mite in the Production of IL-5 and IFN-γ from the Peripheral Blood T Cells of Asthmatic Children, Journal of Korean Medical Science, 2009, 24, 3, 392

    CrossRef

  47. 47
    Harold S. Nelson, Middleton's Allergy: Principles and Practice, 2009,

    CrossRef

  48. 48
    Cheryl S. Hankin, Linda Cox, David Lang, Arthur Levin, Gary Gross, Gene Eavy, Eli Meltzer, Doug Burgoyne, Amy Bronstone, Zhaohui Wang, Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: Patterns of care, resource use, and costs, Journal of Allergy and Clinical Immunology, 2008, 121, 1, 227

    CrossRef

  49. 49
    L. B. Bacharier, A. Boner, K.-H. Carlsen, P. A. Eigenmann, T. Frischer, M. Götz, P. J. Helms, J. Hunt, A. Liu, N. Papadopoulos, T. Platts-Mills, P. Pohunek, F. E. R. Simons, E. Valovirta, U. Wahn, J. Wildhaber, Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report, Allergy, 2008, 63, 1
  50. 50
    Y Zeldin, Z Weiler, A Cohen, M Kalinin, M Schlesinger, M Kidon, E Magen, Efficacy of nasal Staphylococcus aureus eradication by topical nasal mupirocin in patients with perennial allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2008, 100, 6, 608

    CrossRef

  51. 51
    Gabrielle Pauli, Tina H. Larsen, Sabina Rak, Friedrich Horak, Elide Pastorello, Rudolph Valenta, Ashok Purohit, Monica Arvidsson, Alexander Kavina, Jan W. Schroeder, Nadine Mothes, Susanne Spitzauer, Armelle Montagut, Sylvie Galvain, Michel Melac, Claude André, Lars K. Poulsen, Hans-Jorgen Malling, Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis, Journal of Allergy and Clinical Immunology, 2008, 122, 5, 951

    CrossRef

  52. 52
    Susanne Halken, Susanne Lau, Erkka Valovirta, New visions in specific immunotherapy in children: an iPAC summary and future trends, Pediatric Allergy and Immunology, 2008, 19,
  53. 53
    Désirée Larenas-Linnemann, Subcutaneous and sublingual immunotherapy in children: Complete update on controversies, dosing, and efficacy, Current Allergy and Asthma Reports, 2008, 8, 6, 465

    CrossRef

  54. 54
    Robert E. Esch, Robert K. Bush, David Peden, Richard F. Lockey, Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results, Annals of Allergy, Asthma & Immunology, 2008, 100, 5, 475

    CrossRef

  55. 55
    Linda Cox, James T. Li, Harold Nelson, Richard Lockey, Allergen immunotherapy: A practice parameter second update, Journal of Allergy and Clinical Immunology, 2007, 120, 3, S25

    CrossRef

  56. 56
    Giovanni Passalacqua, Stephen R. Durham, Allergic Rhinitis and its Impact on Asthma update: Allergen immunotherapy, Journal of Allergy and Clinical Immunology, 2007, 119, 4, 881

    CrossRef

  57. 57
    Linda Cox, John R. Cohn, Duration of allergen immunotherapy in respiratory allergy: when is enough, enough?, Annals of Allergy, Asthma & Immunology, 2007, 98, 5, 416

    CrossRef

  58. 58
    A. Didier, F. de Blay, L. Tetu, J.C. Dubus, A. Grimfeld, J. Just, P. Demoly, Existe-t-il des traitements spécifiques pour l’asthmatique allergique ?, Revue des Maladies Respiratoires, 2007, 24, 8, 41

    CrossRef

  59. 59
    G. K. Scadding, Further marches: allergic and non-allergic, Clinical & Experimental Allergy, 2007, 37, 4
  60. 60
    Franco Borghesan, Daniela Bernardi, Mario Plebani, In vivo and in vitro allergy diagnostics: it's time to reappraise the costs, Clinical Chemical Laboratory Medicine, 2007, 45, 3

    CrossRef

  61. 61
    B. Mortemousque, Les tests de provocation conjonctivaux, Journal Français d'Ophtalmologie, 2007, 30, 3, 300

    CrossRef

  62. 62
    B. Mortemousque, Les tests de provocation conjonctivaux, Revue Française d'Allergologie et d'Immunologie Clinique, 2007, 47, 4, 318

    CrossRef

  63. 63
    C.M. Reha, A. Ebru, Specific immunotherapy is effective in the prevention of new sensitivities, Allergologia et Immunopathologia, 2007, 35, 2, 44

    CrossRef

  64. 64
    Philippe Stock, Claudia Rolinck-Werninghaus, Ulrich Wahn, Eckard Hamelmann, The Role of Anti-IgE Therapy in Combination with Allergen Specific Immunotherapy for Seasonal Allergic Rhinitis, BioDrugs, 2007, 21, 6, 403

    CrossRef

  65. 65
    A. Didier, Future developments in sublingual immunotherapy, Allergy, 2006, 61,
  66. 66
    Peter S. Creticos, John T. Schroeder, Robert G. Hamilton, Susan L. Balcer-Whaley, Arouna P. Khattignavong, Robert Lindblad, Henry Li, Robert Coffman, Vicki Seyfert, Joseph J. Eiden, David Broide, Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis, New England Journal of Medicine, 2006, 355, 14, 1445

    CrossRef

  67. 67
    David B.K. Golden, Insect sting allergy and venom immunotherapy, Annals of Allergy, Asthma & Immunology, 2006, 96, 2, S16

    CrossRef

  68. 68
    M. Jutel, M. Akdis, K. Blaser, C. A. Akdis, Mechanisms of allergen specific immunotherapy – T-cell tolerance and more, Allergy, 2006, 61, 7
  69. 69
    Steven J. McEldowney, Robert K. Bush, Pollen immunotherapy: Selection, prevention, and future directions, Current Allergy and Asthma Reports, 2006, 6, 5, 420

    CrossRef

  70. 70
    Franziska Ruëff, Special aspects of immunotherapy in children, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2006, 4, 2
  71. 71
    Giovanni B Pajno, Status of immunotherapy: is the time ripe for the secondary prevention of asthma and allergy?, Expert Review of Clinical Immunology, 2006, 2, 4, 485

    CrossRef

  72. 72
    Özlem Keskin, Ayfer Tuncer, Gonul Adalioglu, Bulent E. Sekerel, Cansın Saçkesen, Omer Kalaycı, The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis, Pediatric Allergy and Immunology, 2006, 17, 6
  73. 73
    P. A. Eng, M. Borer-Reinhold, I. A. F. M. Heijnen, H. P. E. Gnehm, Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood, Allergy, 2006, 61, 2
  74. 74
    Marek Jutel, Ultra-Short-Course Seasonal Allergy Vaccine (Pollinex?? Quattro), Drugs, 2006, 66, 7, 939

    CrossRef

  75. 75
    DAISUKE HATA, Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunollogy, 2006, 20, 1, 59

    CrossRef

  76. 76
    P. Rufin, Désensibilisation aux pollens : présaisonnier ou cosaisonnier ?, Revue Française d'Allergologie et d'Immunologie Clinique, 2005, 45, 7, 555

    CrossRef

  77. 77
    C. J. Corrigan, J. Kettner, C. Doemer, O. Cromwell, A. Narkus, Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid, Allergy, 2005, 60, 6
  78. 78
    M. Branco Ferreira, A. Spínola Santos, M.C. Pereira Santos, M.L. Palma Carlos, M.A. Pereira Barbosa, A.G. Palma Carlos, Efficacy and safety of specific immunotherapy with a modified mite extract, Allergologia et Immunopathologia, 2005, 33, 2, 80

    CrossRef

  79. 79
    H. Riechelmann, Immuntherapie mit Allergenextrakten bei allergischer Rhinitis, HNO, 2005, 53, 6, 517

    CrossRef

  80. 80
    Wiqar A. Shaikh, Long-term Efficacy of House Dust Mite Immunotherapy in Bronchial Asthma: A 15-year Follow-up Study, Allergology International, 2005, 54, 3, 443

    CrossRef

  81. 81
    Norbert Reider, Sublingual Immunotherapy for Allergic Rhinoconjunctivitis – The Seeming and the Real, International Archives of Allergy and Immunology, 2005, 137, 3, 181

    CrossRef

  82. 82
    Carlos E Baena-Cagnani, Giovanni Passalacqua, Rodrigo C Baena-Cagnani, Victor H Croce, Walter G Canonica, Sublingual immunotherapy in pediatric patients: beyond clinical efficacy, Current Opinion in Allergy and Clinical Immunology, 2005, 5, 2, 173

    CrossRef

  83. 83
    Takeru Ishikawa, Yoshitaka Okamoto, Keisuke Masuyama, Mucosal Immunology, 2005,

    CrossRef

  84. 84
    Chitra Dinakar, Jay M Portnoy, Allergen immunotherapy in the prevention of asthma, Current Opinion in Allergy and Clinical Immunology, 2004, 4, 2, 131

    CrossRef

  85. 85
    William E Berger, Allergic Rhinitis in Children, Pediatric Drugs, 2004, 6, 4, 233

    CrossRef

  86. 86
    J Just, E Goudard, A Grimfeld, Immunothérapie spécifique : acquis et avenir, Archives de Pédiatrie, 2004, 11, S74

    CrossRef

  87. 87
    Maurizio Marogna, Paolo Falagiani, Marco Bruno, Alessandro Massolo, Graziella Riva, The Allergic March in Pollinosis: Natural History and Therapeutic Implications, International Archives of Allergy and Immunology, 2004, 135, 4, 336

    CrossRef

  88. 88
    Hans-Jørgen Malling, Immunotherapy for rhinitis, Current Allergy and Asthma Reports, 2003, 3, 3, 204

    CrossRef

  89. 89
    Eckard Hamelmann, Claudia Rolinck-Werninghaus, Ulrich Wahn, Is there a role for anti-IgE in combination with specific allergen immunotherapy?, Current Opinion in Allergy and Clinical Immunology, 2003, 3, 6, 501

    CrossRef

  90. 90
    Giorgio Walter Canonica, Giovanni Passalacqua, Noninjection routes for immunotherapy, Journal of Allergy and Clinical Immunology, 2003, 111, 3, 437

    CrossRef

  91. 91
    Giovanni Passalacqua, Carlos E. Baena-Cagnani, Michele Berardi, Giorgio Walter Canonica, Oral and sublingual immunotherapy in paediatric patients, Current Opinion in Allergy and Clinical Immunology, 2003, 3, 2, 139

    CrossRef

  92. 92
    C Ponvert, Quoi de neuf en allergologie pédiatrique en 2002 ? Une revue de la littérature internationale d'octobre 2001 à octobre 2002, Revue Française d'Allergologie et d'Immunologie Clinique, 2003, 43, 1, 69

    CrossRef

  93. 93
    Antibody-mediated specific immunotherapy of allergy, Expert Opinion on Therapeutic Patents, 2002, 12, 6, 949

    CrossRef

  94. 94
    &NA;, Grass pollen immunotherapy beneficial long-term, Inpharma Weekly, 2002, &NA;, 1339, 15

    CrossRef

  95. 95
    Ulrich Wahn, Immunotherapy in children, Current Opinion in Allergy and Clinical Immunology, 2002, 2, 6, 557

    CrossRef

  96. 96
    Ira Finegold, Is immunotherapy effective in allergic disease?, Current Opinion in Allergy and Clinical Immunology, 2002, 2, 6, 537

    CrossRef

  97. 97
    J Bousquet, P Demoly, L'immunothérapie modifie l'histoire naturelle des maladies allergiques et prévient l'apparition de nouvelles sensibilisations, Revue Française d'Allergologie et d'Immunologie Clinique, 2002, 42, 6, 595

    CrossRef

  98. 98
    G. Passalacqua, G. W. Canonica, Long-lasting clinical efficacy of allergen specific immunotherapy, Allergy, 2002, 57, 4